BNT162b2 vaccine induces antibody release in saliva: a possible role for mucosal viral protection?
Abstract Vaccination against an airborne pathogen is very effective if it induces also the development of mucosal antibodies that can protect against infection. The mRNA‐based vaccine‐encoding SARS‐CoV‐2 full‐length spike protein (BNT162b2, Pfizer/BioNTech) protects also against infection despite be...
Saved in:
Similar Items
-
Neurocysticercosis: detection of IgG, IgA and IgE antibodies in cerebrospinal fluid, serum and saliva samples by ELISA with Taenia solium and Taenia crassiceps antigens
by: EDNÉIA CASAGRANDA BUENO, et al.
Published: (2000-03-01) -
Localised Chronic Fibrosing Vasculitis in a 6 Year Old Boy Clinically Mimicking Dermatofibrosarcoma Protuberans
by: Michela Brena, et al.
Published: (2025-06-01) -
Immunoglobulin Concentrations in Plasma and Saliva During the Neonatal Period
by: Sandra Pineda-Martínez, et al.
Published: (2016-06-01) -
Immunoglobulin gene loci structure and diversity of raccoon dog (Nyctereutes procyonoides)
by: Xiaohua Yi, et al.
Published: (2025-04-01) -
Efficacy and Safety of Telitacicept as an Add-On Therapy for Refractory Immunoglobulin A Nephropathy or Immunoglobulin A Vasculitis Nephropathy in Children
by: Jiaojiao Liu, et al.
Published: (2025-03-01)